Multiomics profiling and experiments in preclinical models revealed RAD51-IN-1 as a synergistic potentiator of anlotinib sensitivity.

Sci Adv · 2026 · PMC13082322 · PMID 41984951

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Other genes such as NOTCH1 , PRKD1 , TBX3 , and WNK2 showed higher mutation rates in the resistant group (each 50% versus 8.3%, P = 0.0833), although the differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.